2020年11月27日全球新冠肺炎(COVID-19)疫情简报,确诊超6127万,阿斯利康疫苗再受质疑

2020-11-27 MedSci整理 MedSci整理

Worldometers世界实时统计数据显示,截至北京时间11月27日7时03分,全球新冠肺炎(COVID-19)累计确诊病例超过6127万例,达到61,270,627例,其中昨日新增超57万,累计死

Worldometers世界实时统计数据显示,截至北京时间11月27日7时03分,全球新冠肺炎COVID-19)累计确诊病例超过6127万例,达到61,270,627例,其中昨日新增超57万,累计死亡病例超过143.6万例,达到1,436,706例,康复为42,352,315例,重症和危重症病人达到104,729例,65个国家病例超10万例。美国新冠肺炎累计确诊病例全球最多,超过1323万例,达到13,237,338例;累计死亡病例超过26.9万例,达到269,441例。昨日报道:2020年11月26日全球新冠肺炎(COVID-19)疫情简报,确诊超6067万

阿斯利康的疫苗数据随即遭遇质疑,阿斯利康CEO称可能会在全球进行新一轮新冠疫苗试验

11月23日公布的最新试验结果显示,阿斯利康/牛津大学研发疫苗对新冠病毒的平均有效性为70%,没有与疫苗有关的严重安全事件。当时,牛津大学根据三期临床的中期数据指出,他们进行了两种不同剂量的试验后发现,先用一半剂量后再接种全剂量时,疫苗有效程度最高可达90%,而接种完整两剂的有效性仅为62%,生产过程的不同导致一些受试者接种了半剂而非完整一剂。

正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。阿斯利康和牛津大学几乎没有公布进一步的细节,令外界担心监管层是否会放行。由于阿斯利康的疫苗更易于存储,而且售价和制造成本相对更低,可能意味着在全球中低收入国家的防疫中发挥重要作用,因而备受瞩目。

由于目前的研究令阿斯利康新冠疫苗的有效性面临质疑,该公司首席执行官表示,可能会进行一轮额外的全球试验,以评估疫苗的功效。

数据发布的一天后,美国疫苗项目Operation Warp Speed的负责人表示,有效性较高的结果是在较年轻的受试者身上获得的,而一些人之所以接种了半剂,是因为疫苗装瓶时发生了错误,而阿斯利康或牛津大学的原始声明中并没有披露任何的相关信息。

阿斯利康曾在本月称,其研发的新冠疫苗能在老年人中产生强大的免疫反应,对老年人的副作用要小于对年轻人的副作用。11月5日公布季度财报时,公司CEO称,如果疫苗最终证明有效,将在“尽可能多的国家同时”申请紧急使用授权,明年1月前有望提供数亿剂。欧洲和英国监管机构正在对候选疫苗进行滚动或加速审查。

周四美股因感恩节假期休市一日,阿斯利康英股盘中最深跌1.1%,随后跌幅收窄至0.7%,股价接近一个月新低。本周一至周三其美股累跌近5%,创11月3日以来最低。

美国预计12月新冠肺炎死亡人数破30万 部分美国人被迫改变过节方式

当地时间11月25日,美疾控中心发布一项全国疫情总体预报,预测到12月19日,美国死亡人数将上升至294000至321000人。今年,美国感恩节大游行期间并没有出现明显人群聚集,许多美国人选择独自度过。一些家庭选择通过视频通话的方式共同进餐。

日本菊头蝙蝠身上发现类似新冠状病毒的相似度达80%

日本东京大学病毒学副教授村上晋等人组成的研究小组在美国疾病控制和预防中心(CDC)的专业杂志上发表研究成果称重 ,据日本报道,发现病毒的是2013年在岩手县附近中捕获的角菊头蝠的粪便,其解析遗传信息发现其与新冠状病毒 一致度达到80%左右,“似乎属于同种病毒群”。 日本共同社26日报道称,由于该病毒不会感染人类的细胞,故村上认为“这种病毒并非新冠状病毒的直接源头”,但他擅长,为了日本不发生人畜共患传染病,“有必要 详细调查野生动物带有怎样的病毒,是否可能传染给人类”。

60余位中国公民在埃及出差或中转新冠检测实

中国驻埃及大使馆发布提醒:11月初以来,我馆陆续接报60余例临时来埃出差或中转回国中国公民在埃检测结果为阳性案例。经了解,凡检测结果为阳性的来埃中转回国人员或外国乘客均需在埃隔离治疗1个月以上时间,待完全康复转阴后方可再次申请登机HS码或HDC码。 鉴此,我馆建议中国公民慎重选择来埃中转,避免跨境旅行,降低感染风险,以免造成健康 ,经济及时间损失。

联合国:疫情或使全球女性肥胖倒退25年

根据联合国妇女署最新的全球数据显示,新冠疫情可能会使他们为之的努力的性别平等工作倒退25年。由于新冠疫情,女性强迫家务和家庭护理的 联合国妇女署副总干事安妮塔·巴蒂亚说,“仅在9月份,美国就有约86.5万 疫情之前,在全世界每天160亿小时的无偿工作中,女性负担了约75%,其中女性原因是护理负担重,没有其他人可分担”。 是男性的3倍。

美国华特迪士尼公司计划裁员32000人

据美国证券交易委员会的文件披露,美国华特迪士尼公司因新冠肺炎疫情持续打击其公园和度假村业务,计划在2021年3月底前裁员32000人。

欧美自锁以来首次首次恢复跨大西洋航班服务:意大利允许执行从美国航线欧洲的免隔离航班

美国达美航空表示,该航司将恢复跨大西洋航班服务-从美国亚特兰大(机场)飞往意大利 罗马费米奇诺机场,按新版防疫制度,飞机离港前,落地后都将接受严格的新冠肺炎病毒检测。意大利航空公司(Alitalia)也将按同样的流程执飞从罗马前往纽约肯尼迪机场的航班 。值得一提的是,可以飞行航班都只能执行单程服务,美国方面禁止第三国人员入境意大利,甚至是美国公民也必须前往意大利的“某些必要理由”。国际航空运输协会(IATA) 表示,在其了解的范围内,那将是美国与欧洲之间恢复运营的首条航线。

瑞典王子菲利普与索菲娅王妃确诊感染新冠肺炎

当地时间11月26日,瑞典电视台报道,瑞典王子卡尔·菲利普和索菲娅王妃的新冠病毒检测呈阳性,目前他们进行了自我隔离。此外,瑞典的国王、王后、维多利亚公主和丹尼尔亲王都将接受新冠病毒检测。

瑞典从“前所未有的”严厉措施

据俄罗斯卫星社日前报道,经济合作与发展组织(OECD)将瑞典列为欧洲抗击新冠状病情最严重的国家,再加上新冠重症监护患者有增无减。 瑞典首相勒文称,对聚会人数的限制措施是瑞典现代史上“前所未有的”。

世界银行:新冠肺炎疫情致肯尼亚贫困人口增加200万 经济将萎缩1%

肯尼亚媒体11月26日报道,世界银行的一份最新报告显示,新冠肺炎疫情致肯尼亚贫困人口增加200万,超过五分之一的肯尼亚企业进行了裁员。世界银行的报告称肯尼亚经济已陷入衰退,预测肯2020年经济将萎缩1%,最差的情况下或萎缩1.5%。

英国公布本轮严控结束后新防疫措施

英国首相鲍里斯·约翰逊26日在唐宁街10号首相府举行新闻发布会,公布在12月2日英格兰地区结束本轮严格管控措施之后英国将采取的新防疫措施。在本轮严格管控措施结束后,英国将引入新的三级防疫管控措施,英国各地将分别根据当地疫情各自决定各级警戒措施。

希腊将全国性封锁措施延长一周

希腊政府11月26日宣布将全国性的封锁举措延长一周,以应对新冠肺炎疫情不断恶化的挑战。

本月初,希腊政府决定在11月7日至11月30日之间实施第二轮全国性封锁。但是近来新冠肺炎死亡病例和重症病例仍在加速增加,单日确诊病例基本处于2000例以上,距离降至500例以下的目标相去甚远。因此在医学防疫专家的建议下,希腊政府做出了延长封锁期的决定。

印度将国际航班停运时间延长至12月31日

根据《印度斯坦时报》报道,印度民航总局(DGCA)表示,鉴于新冠肺炎疫情,已决定将进出印度的国际航班停运时间延长到今年12月31日,经过印度民航总局批准的国际货运和少数航班不在此列。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1735155, encodeId=7ff31e35155f4, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Jan 01 01:12:15 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903402, encodeId=b4dd9034025e, content=加强预防,提高免疫力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sun Nov 29 22:58:34 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902947, encodeId=14a890294e0d, content=正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/2a7304a6d86a4613b3630c560cb04e8b/87ff2479a1534242b2522e7bb3c9b715.jpg, createdBy=5b9a5439163, createdName=ms7000000281206380, createdTime=Fri Nov 27 21:32:16 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902806, encodeId=0b2c90280691, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff504672922, createdName=gaoboanswer, createdTime=Fri Nov 27 14:24:45 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902742, encodeId=beeb902e42e8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Fri Nov 27 10:58:59 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028820, encodeId=334d102882062, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Nov 27 10:12:15 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902687, encodeId=10d290268e66, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4415438974, createdName=ms4000001308842842, createdTime=Fri Nov 27 08:27:06 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902668, encodeId=07a79026680d, content=美国疫苗可靠性存疑, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Nov 27 07:16:08 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2021-01-01 saikp
  2. [GetPortalCommentsPageByObjectIdResponse(id=1735155, encodeId=7ff31e35155f4, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Jan 01 01:12:15 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903402, encodeId=b4dd9034025e, content=加强预防,提高免疫力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sun Nov 29 22:58:34 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902947, encodeId=14a890294e0d, content=正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/2a7304a6d86a4613b3630c560cb04e8b/87ff2479a1534242b2522e7bb3c9b715.jpg, createdBy=5b9a5439163, createdName=ms7000000281206380, createdTime=Fri Nov 27 21:32:16 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902806, encodeId=0b2c90280691, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff504672922, createdName=gaoboanswer, createdTime=Fri Nov 27 14:24:45 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902742, encodeId=beeb902e42e8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Fri Nov 27 10:58:59 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028820, encodeId=334d102882062, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Nov 27 10:12:15 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902687, encodeId=10d290268e66, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4415438974, createdName=ms4000001308842842, createdTime=Fri Nov 27 08:27:06 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902668, encodeId=07a79026680d, content=美国疫苗可靠性存疑, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Nov 27 07:16:08 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-29 言西早

    加强预防,提高免疫力

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1735155, encodeId=7ff31e35155f4, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Jan 01 01:12:15 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903402, encodeId=b4dd9034025e, content=加强预防,提高免疫力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sun Nov 29 22:58:34 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902947, encodeId=14a890294e0d, content=正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/2a7304a6d86a4613b3630c560cb04e8b/87ff2479a1534242b2522e7bb3c9b715.jpg, createdBy=5b9a5439163, createdName=ms7000000281206380, createdTime=Fri Nov 27 21:32:16 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902806, encodeId=0b2c90280691, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff504672922, createdName=gaoboanswer, createdTime=Fri Nov 27 14:24:45 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902742, encodeId=beeb902e42e8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Fri Nov 27 10:58:59 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028820, encodeId=334d102882062, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Nov 27 10:12:15 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902687, encodeId=10d290268e66, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4415438974, createdName=ms4000001308842842, createdTime=Fri Nov 27 08:27:06 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902668, encodeId=07a79026680d, content=美国疫苗可靠性存疑, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Nov 27 07:16:08 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 ms7000000281206380

    正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1735155, encodeId=7ff31e35155f4, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Jan 01 01:12:15 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903402, encodeId=b4dd9034025e, content=加强预防,提高免疫力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sun Nov 29 22:58:34 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902947, encodeId=14a890294e0d, content=正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/2a7304a6d86a4613b3630c560cb04e8b/87ff2479a1534242b2522e7bb3c9b715.jpg, createdBy=5b9a5439163, createdName=ms7000000281206380, createdTime=Fri Nov 27 21:32:16 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902806, encodeId=0b2c90280691, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff504672922, createdName=gaoboanswer, createdTime=Fri Nov 27 14:24:45 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902742, encodeId=beeb902e42e8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Fri Nov 27 10:58:59 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028820, encodeId=334d102882062, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Nov 27 10:12:15 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902687, encodeId=10d290268e66, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4415438974, createdName=ms4000001308842842, createdTime=Fri Nov 27 08:27:06 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902668, encodeId=07a79026680d, content=美国疫苗可靠性存疑, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Nov 27 07:16:08 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 gaoboanswer

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1735155, encodeId=7ff31e35155f4, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Jan 01 01:12:15 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903402, encodeId=b4dd9034025e, content=加强预防,提高免疫力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sun Nov 29 22:58:34 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902947, encodeId=14a890294e0d, content=正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/2a7304a6d86a4613b3630c560cb04e8b/87ff2479a1534242b2522e7bb3c9b715.jpg, createdBy=5b9a5439163, createdName=ms7000000281206380, createdTime=Fri Nov 27 21:32:16 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902806, encodeId=0b2c90280691, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff504672922, createdName=gaoboanswer, createdTime=Fri Nov 27 14:24:45 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902742, encodeId=beeb902e42e8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Fri Nov 27 10:58:59 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028820, encodeId=334d102882062, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Nov 27 10:12:15 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902687, encodeId=10d290268e66, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4415438974, createdName=ms4000001308842842, createdTime=Fri Nov 27 08:27:06 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902668, encodeId=07a79026680d, content=美国疫苗可靠性存疑, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Nov 27 07:16:08 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 392534278

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1735155, encodeId=7ff31e35155f4, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Jan 01 01:12:15 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903402, encodeId=b4dd9034025e, content=加强预防,提高免疫力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sun Nov 29 22:58:34 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902947, encodeId=14a890294e0d, content=正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/2a7304a6d86a4613b3630c560cb04e8b/87ff2479a1534242b2522e7bb3c9b715.jpg, createdBy=5b9a5439163, createdName=ms7000000281206380, createdTime=Fri Nov 27 21:32:16 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902806, encodeId=0b2c90280691, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff504672922, createdName=gaoboanswer, createdTime=Fri Nov 27 14:24:45 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902742, encodeId=beeb902e42e8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Fri Nov 27 10:58:59 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028820, encodeId=334d102882062, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Nov 27 10:12:15 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902687, encodeId=10d290268e66, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4415438974, createdName=ms4000001308842842, createdTime=Fri Nov 27 08:27:06 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902668, encodeId=07a79026680d, content=美国疫苗可靠性存疑, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Nov 27 07:16:08 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1735155, encodeId=7ff31e35155f4, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Jan 01 01:12:15 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903402, encodeId=b4dd9034025e, content=加强预防,提高免疫力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sun Nov 29 22:58:34 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902947, encodeId=14a890294e0d, content=正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/2a7304a6d86a4613b3630c560cb04e8b/87ff2479a1534242b2522e7bb3c9b715.jpg, createdBy=5b9a5439163, createdName=ms7000000281206380, createdTime=Fri Nov 27 21:32:16 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902806, encodeId=0b2c90280691, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff504672922, createdName=gaoboanswer, createdTime=Fri Nov 27 14:24:45 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902742, encodeId=beeb902e42e8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Fri Nov 27 10:58:59 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028820, encodeId=334d102882062, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Nov 27 10:12:15 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902687, encodeId=10d290268e66, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4415438974, createdName=ms4000001308842842, createdTime=Fri Nov 27 08:27:06 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902668, encodeId=07a79026680d, content=美国疫苗可靠性存疑, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Nov 27 07:16:08 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 ms4000001308842842

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1735155, encodeId=7ff31e35155f4, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Jan 01 01:12:15 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903402, encodeId=b4dd9034025e, content=加强预防,提高免疫力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sun Nov 29 22:58:34 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902947, encodeId=14a890294e0d, content=正因阿斯利康的试验存在纰漏,各方对其疫苗的疑问越来越多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/2a7304a6d86a4613b3630c560cb04e8b/87ff2479a1534242b2522e7bb3c9b715.jpg, createdBy=5b9a5439163, createdName=ms7000000281206380, createdTime=Fri Nov 27 21:32:16 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902806, encodeId=0b2c90280691, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff504672922, createdName=gaoboanswer, createdTime=Fri Nov 27 14:24:45 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902742, encodeId=beeb902e42e8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Fri Nov 27 10:58:59 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028820, encodeId=334d102882062, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Nov 27 10:12:15 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902687, encodeId=10d290268e66, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4415438974, createdName=ms4000001308842842, createdTime=Fri Nov 27 08:27:06 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902668, encodeId=07a79026680d, content=美国疫苗可靠性存疑, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Nov 27 07:16:08 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 yangchou

    美国疫苗可靠性存疑

    0

相关资讯

JAMA Pediatr:美国儿童及青少年新冠肺炎流行病学研究

在这项针对美国儿科患者的大型队列研究中,儿童的SARS-CoV-2感染率较低,临床表现一般较轻。黑人、西班牙裔和亚洲人群;青春期和成年早期;非呼吸性慢性疾病人群的感染风险较高

Nature:日本和柬埔寨发现与新冠密切相关的冠状病毒!

病毒的源头虽然还未查明,但溯源工作一直在进行着。《Nature》头条新闻发布关于新冠病毒溯源工作的最新消息。

2020年11月26日全球新冠肺炎(COVID-19)疫情简报,确诊超6067万

Worldometers世界实时统计数据显示,截至北京时间11月26日7时21分,全球新冠肺炎(COVID-19)累计确诊病例超过6067万例,达到60,671,662例,其中昨日新增超57万,累计死

Science :复旦大学余宏杰课题组在新冠肺炎的传播动力学与非药物性干预措施效果领域取得重要进展

近期,复旦大学公共卫生学院余宏杰课题组牵头,联合湖南省疾病预防控制中心、美国国立卫生研究院等团队,在新型冠状病毒肺炎的传播动力学与非药物性干预措施的防控效果研究领域取得重要进展。

2020年11月25日全球新冠肺炎(COVID-19)疫情简报,确诊超6007万,仅用18天就超1000万,疫苗难以全球公平分配

Worldometers世界实时统计数据显示,截至北京时间11月25日8时38分,全球新冠肺炎(COVID-19)累计确诊病例超过6007万例,达到60,077,372例,其中昨日新增超53万,累计死

NEJM:新冠患者的恢复期血浆——被高估的抗体治疗

2019年末,由SARS-CoV-2病毒引起的新型冠状肺炎Covid-19引发了全球大流行,并致使数百万人被感染。而到目前为止,只有两种药物在进行的大型随机对照试验中显示出了一定程度的临床疗效。一是瑞